Efficacy of Biologics in the Treatment of Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Cureus · 2024 · PMC10939508 · PMID 38487649

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep = 0.10so close (0.05 < p ≤ 0.1)

Notably, although there was a reduction in ALP levels following six months of adalimumab therapy, this reduction did not reach statistical significance (SMD = -0.38, CI [-0.84, 0.08], I 2 = 0, p = 0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.